Schinus terebinthifolius administration prevented behavioral and biochemical alterations in a rotenone model of Parkinson's disease

被引:10
|
作者
Sereniki, Adriana [1 ]
Linard-Medeiros, Cybelle F. B. [1 ]
Silva, Shirliane N. [2 ]
Silva, Juciene B. R. [1 ]
Peixoto Sobrinho, Tadeu J. S. [2 ]
da Silva, Juliano R. [1 ]
Alves, Lariza D. S. [1 ]
Smaili, Soraya S. [3 ]
Wanderley, Almir G. [1 ,2 ]
Lafayette, Simone S. L. [1 ,2 ]
机构
[1] Univ Fed Pernambuco, Dept Ciencias Farmaceut, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil
[3] Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, SP, Brazil
关键词
Antioxidant effects; Lipidic peroxidation; Parkinson's disease; Rotenone; Schinus terebinthifolius; ALPHA-SYNUCLEIN AGGREGATION; TEA POLYPHENOLS; ANTIOXIDANT; RAT; MECHANISMS; INJURY; DAMAGE; BRAIN; ACID;
D O I
10.1016/j.bjp.2015.11.005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Parkinson's disease is a neurodegenerative disorder characterized by motor impairment, cognitive decline and psychiatric symptoms. Schinus terebinthifolius Raddi, Anacardiaceae, had been studied for its anti-inflammatory and antioxidant properties, and in this study, the stem bark was evaluated for the neuroprotective effects on behavioral and biochemical alterations induced by administrations of rotenone in rats. Behavioral evaluations were performed using open-field and rotarod. The in vitro and in vivo antioxidant activities were determined by the DPPH radical scavenging activity and lipid peroxidation method respectively. The administration of rotenone (3 mg/kg, s.c.) produced hypolocomotion, increase of immobility and muscle incoordination, while the treatment with S. terebinthifolius stem bark extract (150, 300 and 600 mg/kg p.o.) for seven days prevented rotenone-induced dysfunctional behavior. Biochemical analysis of the substantia nigra, striatum and cortex revealed that rotenone administration significantly increased lipid peroxidation, which was inhibited by treatment with all doses of S. terebinthifolius. The results suggested neuroprotective effect of S. terebinthifolius possibly mediated through its antioxidant activity, indicating a potential therapeutic benefit of this species in the treatment of Parkinson's disease. (C) 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [41] Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease
    Tiago Zaminelli
    Raísa Wendhausen Gradowski
    Taysa Bervian Bassani
    Janaína Kohl Barbiero
    Ronise M. Santiago
    Daniele Maria-Ferreira
    Cristiane Hatsuko Baggio
    Maria A. B. F. Vital
    Neurotoxicity Research, 2014, 26 : 351 - 362
  • [42] Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson's Disease
    Zaminelli, Tiago
    Gradowski, Raisa Wendhausen
    Bassani, Taysa Bervian
    Barbiero, Janaina Kohl
    Santiago, Ronise M.
    Maria-Ferreira, Daniele
    Baggio, Cristiane Hatsuko
    Vital, Maria A. B. F.
    NEUROTOXICITY RESEARCH, 2014, 26 (04) : 351 - 362
  • [43] Rotenone model of Parkinson's disease: The dosing options in mice revisited
    Raza, M.
    Zehra, N.
    Malhi, S.
    MOVEMENT DISORDERS, 2018, 33 : S405 - S405
  • [44] A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease
    Huang, J
    Liu, HQ
    Gu, WW
    Yan, Z
    Xu, ZH
    Yang, YX
    Zhu, XZ
    Li, YP
    BIOMATERIALS, 2006, 27 (06) : 937 - 946
  • [45] Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
    Ulusoy, Gokhan K.
    Celik, Turgay
    Kayir, Hakan
    Gursoy, Murat
    Isik, Ahmet T.
    Uzbay, Tayfun I.
    BRAIN RESEARCH BULLETIN, 2011, 85 (06) : 380 - 384
  • [46] Dysregulation of striatal neurotransmitter release in the rotenone model of Parkinson's disease
    Sperlágh, B
    Milusheva, E
    Baranyi, M
    Kittel, A
    Vizi, ES
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 120 - 120
  • [47] IMIPRAMINE AND AMITRIPTYLINE AMELIORATE THE ROTENONE MODEL OF PARKINSON'S DISEASE IN RATS
    Kandil, Esraa A.
    Abdelkader, Noha F.
    El-Sayeh, Bahia M.
    Saleh, Samira
    NEUROSCIENCE, 2016, 332 : 26 - 37
  • [48] Selective microglial activation in the rat rotenone model of Parkinson's disease
    Sherer, TB
    Betarbet, R
    Kim, JH
    Greenamyre, JT
    NEUROSCIENCE LETTERS, 2003, 341 (02) : 87 - 90
  • [49] Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
    Xiong, Nian
    Xiong, Jing
    Khare, Ghanshyam
    Chen, Chunnuan
    Huang, Jinsha
    Zhao, Ying
    Zhang, Zhentao
    Qiao, Xian
    Feng, Yuan
    Reesaul, Harrish
    Zhang, Yongxue
    Sun, Shenggang
    Lin, Zhicheng
    Wang, Tao
    PLOS ONE, 2011, 6 (06):
  • [50] Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
    Xiong, Nian
    Huang, Jinsha
    Zhang, Zhentao
    Zhang, Zhaowen
    Xiong, Jing
    Liu, Xingyuan
    Jia, Min
    Wang, Fang
    Chen, Chunnuan
    Cao, Xuebing
    Liang, Zhihou
    Sun, Shenggang
    Lin, Zhicheng
    Wang, Tao
    PLOS ONE, 2009, 4 (11):